SEC Form 4/A · accession 0001209191-15-004308

Juno Therapeutics, Inc. · JUNO

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

This is an amendment (Form 4/A). It replaces an earlier filing for the same period.

Reporting owner

Officer — General Counsel and Secretary

Period of report

Dec 23, 2014

Accepted (ET)

Jan 15, 2015 · 6:06 am EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001594864

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock^F1	Dec 23, 2014	C	25,000	—	A	25,000	I	By Morgan Stanley Smith Barney LLC as Custodian for Bernard Cassidy IRA
Common Stock^F3,F2	Dec 23, 2014	C	1,869	—	A	26,869	I	By Morgan Stanley Smith Barney LLC as Custodian for Bernard Cassidy IRA
Common Stock^F4	holding	—	—		—	125,000	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Series A-2 Preferred Stock^F1	—	Dec 23, 2014	C	25,000	D	—	—	Common Stock	25,000	0	I
Series B Preferred Stock^F3,F2	—	Dec 23, 2014	C	1,869	D	—	—	Common Stock	1,869	0	I

F1The Series A-2 Preferred Stock converted into Common Stock on a 1-for-1 basis immediately prior to the completion of the Issuer's initial public offering of common stock and had no expiration date.
F2The Series B Preferred Stock converted into Common Stock on a 1-for-1 basis immediately prior to the completion of the Issuer's initial public offering of common stock and had no expiration date
F3This Amendment to Form 4 is filed solely for the purpose of correcting a clerical error in the amount of Series B Preferred Stock converted into Common Stock upon the Issuer's initial public offering and the resulting total number of shares indirectly owned, as reported on the Form 4 filed December 23, 2014.
F4Includes 125,000 shares of restricted stock as of December 23, 2014.